Last reviewed: May 15, 2026 Last updated: May 15, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
doi:10.1016/j.dsx.2025.103212
I also wore a CGM and played around with meal sizes and amounts of sugar, but energy levels and blood sugar did not seem to correlate much
In the latest edition of Future magazine, UT Health San Antonio experts discuss novel prevention strategies, remote monitoring tools for early injury detection and emerging treatments that are improving outcomes for patients with Type 2 diabetes: To view or add a comment, sign in Finally a discussion on prediabetes
Bulk buying during this period, while supply is available and pricing is market-driven rather than pharmacy-driven, may be strategically advantageous